Clinical Differences in Patients Infected with Fusobacterium and Antimicrobial Susceptibility of Fusobacterium Isolates Recovered at a Tertiary-Care Hospital in Korea
2022; 42(2): 188-195
Ann Lab Med 2020; 40(4): 326-330
Published online July 1, 2020 https://doi.org/10.3343/alm.2020.40.4.326
Copyright © Korean Society for Laboratory Medicine.
1Department of Laboratory Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea; 2Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea; 3Department of Laboratory Medicine, Boramae Hospital, Seoul National University College of Medicine, Seoul, Korea; 4GC Genome, Yongin, Korea
Correspondence to: Sue Shin, M.D.
Department of Laboratory Medicine, Boramae Hospital, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea
Tel: +82 2-870-2602 Fax: +82 2-870-2620. E-mail: email@example.com
Chang-Seok Ki, M.D.
GC Genome, 107 Ihyeon-ro 30beon-gil, Giheung-gu, Yongin 16924, Korea
Tel: +82-31-260-0601 Fax: +82-31-260-9087. E-mail: firstname.lastname@example.org
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by progressive proximal muscle weakness and atrophy. Given the recent introduction of gene therapies, knowledge of the SMA carrier frequency in various populations has become important for developing screening programs for this disease. In total, 1,581 anonymous DNA samples from an umbilical cord blood bank were tested for
Keywords: Korea, Spinal muscular atrophy, Carrier frequency, multiplex ligation-dependent probe amplification